Current research in toxicology is focusing on identifying biomarkers that can predict changes in platelet count due to toxic exposure. Studies are also exploring novel therapeutic approaches to mitigate the hematological effects of toxins. There is growing interest in understanding the genetic factors that influence individual susceptibility to toxin-induced platelet count alterations.
